Combined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients With Severe Community-Acquired Pneumonia

NCT03452826 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

411

Enrollment

OTHER

Sponsor class

Conditions

Community-acquired Pneumonia

Interventions

DEVICE: Antibiotic therapy according to the result of mPCR (device)

Sponsor

Assistance Publique - Hôpitaux de Paris